Cost-effectiveness of 12-monthly point-of-care viral load monitoring (strategy 4.2) compared with clinical monitoring (strategy 2.1), assuming that the risk of virological failure is either identical in both strategies (Scenario A) or twice as high with viral load monitoring than with clinical monitoring (Scenario B).

All performed sensitivity analyses are listed in S1 Table and their full results in S2 to S11 Tables of the Supplementary Material. The results of Analysis CD1 are not shown since the cost of CD4 test does not influence either strategy. The input values used in the main analysis are shown in Table 3.
Cost-effectiveness of 12-monthly point-of-care viral load monitoring (strategy 4.2) compared with clinical monitoring (strategy 2.1), assuming that the risk of virological failure is either identical in both strategies (Scenario A) or twice as high with viral load monitoring than with clinical monitoring (Scenario B).